• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Regulation of epidermal growth factor receptor levels by thyroid hormone.甲状腺激素对表皮生长因子受体水平的调节
J Biol Chem. 1984 May 25;259(10):6543-7.
2
Thyroid hormone regulation of epidermal growth factor receptor levels in mouse mammary glands.甲状腺激素对小鼠乳腺中表皮生长因子受体水平的调节
Endocrinology. 1986 Aug;119(2):580-5. doi: 10.1210/endo-119-2-580.
3
Regulation of epidermal growth factor receptor number and phosphorylation by fasting in rat liver.禁食对大鼠肝脏表皮生长因子受体数量及磷酸化的调节作用
J Biol Chem. 1986 Jan 15;261(2):752-7.
4
Receptors for epidermal growth factor in the rat uterus.大鼠子宫中的表皮生长因子受体。
Endocrinology. 1985 Jul;117(1):149-54. doi: 10.1210/endo-117-1-149.
5
Expression of hepatic transforming growth factor receptors during late gestation in the fetal rat.胎鼠妊娠晚期肝脏转化生长因子受体的表达
Endocrinology. 1989 Dec;125(6):3037-43. doi: 10.1210/endo-125-6-3037.
6
Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells.表皮生长因子样转化生长因子。II. 与人胎盘膜和A431细胞中表皮生长因子受体的相互作用。
J Biol Chem. 1983 Nov 25;258(22):13614-20.
7
Correlation of membrane phosphorylation and epidermal growth factor binding to hepatic membranes isolated from triiodothyronine-treated rats.
Biochim Biophys Acta. 1983 May 5;730(2):226-30. doi: 10.1016/0005-2736(83)90337-1.
8
Alteration of epidermal growth factor-dependent phosphorylation during rat liver regeneration.大鼠肝脏再生过程中表皮生长因子依赖性磷酸化的改变。
Proc Natl Acad Sci U S A. 1982 Feb;79(3):776-80. doi: 10.1073/pnas.79.3.776.
9
Thyroid-dependent maturation of neonatal brain but not lung epidermal growth factor receptors.
Dev Pharmacol Ther. 1985;8(5):292-301. doi: 10.1159/000457052.
10
Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamster.
Proc Natl Acad Sci U S A. 1984 Dec;81(23):7407-11. doi: 10.1073/pnas.81.23.7407.

引用本文的文献

1
The Retinol Circulating Complex Releases Hormonal Ligands During Acute Stress Disorders.视黄醇循环复合物在急性应激障碍期间释放激素配体。
Front Endocrinol (Lausanne). 2018 Sep 4;9:487. doi: 10.3389/fendo.2018.00487. eCollection 2018.
2
Prognostic and Predictive Factors for Renal Cell Carcinoma.肾细胞癌的预后和预测因素。
Target Oncol. 2018 Jun;13(3):309-331. doi: 10.1007/s11523-018-0557-2.
3
Transcriptional down-regulation of epidermal growth factor (EGF) receptors by nerve growth factor (NGF) in PC12 cells.神经生长因子(NGF)对PC12细胞中表皮生长因子(EGF)受体的转录下调作用。
J Mol Neurosci. 2014 Nov;54(3):574-85. doi: 10.1007/s12031-014-0388-2. Epub 2014 Jul 31.
4
Epidermal growth factor receptor plays a role in the regulation of liver and plasma lipid levels in adult male mice.表皮生长因子受体在成年雄性小鼠肝脏和血浆脂质水平的调节中发挥作用。
Am J Physiol Gastrointest Liver Physiol. 2014 Mar 1;306(5):G370-81. doi: 10.1152/ajpgi.00116.2013. Epub 2014 Jan 9.
5
Central role of the EGF receptor in neurometabolic aging.EGF 受体在神经代谢衰老中的核心作用。
Int J Endocrinol. 2012;2012:739428. doi: 10.1155/2012/739428. Epub 2012 Jun 17.
6
Toxicity as a biomarker of efficacy of molecular targeted therapies: focus on EGFR and VEGF inhibiting anticancer drugs.毒性作为分子靶向治疗疗效的生物标志物:以 EGFR 和 VEGF 抑制抗癌药物为例。
Oncologist. 2011;16(12):1729-40. doi: 10.1634/theoncologist.2011-0163. Epub 2011 Dec 1.
7
Reduced expression of epidermal growth factor receptors in rat liver during aging.衰老过程中大鼠肝脏中表皮生长因子受体表达降低。
J Gerontol A Biol Sci Med Sci. 2008 Jul;63(7):683-92. doi: 10.1093/gerona/63.7.683.
8
EGF receptor expression, regulation, and function in breast cancer.表皮生长因子受体在乳腺癌中的表达、调控及功能
Breast Cancer Res Treat. 1994 Jan;29(1):29-40. doi: 10.1007/BF00666179.
9
Mechanisms of EGF receptor regulation in breast cancer cells.乳腺癌细胞中表皮生长因子受体的调控机制
Breast Cancer Res Treat. 1994;31(2-3):227-36. doi: 10.1007/BF00666156.
10
2,3,7,8-Tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains.2,3,7,8-四氯二苯并对二恶英会导致反应性小鼠品系特定组织中c-erb-A表达增加以及蛋白酪氨酸激酶水平升高。
Proc Natl Acad Sci U S A. 1988 Jun;85(12):4128-32. doi: 10.1073/pnas.85.12.4128.

甲状腺激素对表皮生长因子受体水平的调节

Regulation of epidermal growth factor receptor levels by thyroid hormone.

作者信息

Mukku V R

出版信息

J Biol Chem. 1984 May 25;259(10):6543-7.

PMID:6327683
Abstract

The binding of iodinated epidermal growth factor (125I-EGF) to membrane preparations from the livers of euthyroid and hypothyroid rats was examined to determine if thyroid hormones regulate EGF receptors. Binding in membrane preparations from hypothyroid livers was only 30-40% compared to that of euthyroid controls. Treatment of hypothyroid animals with a single dose of L-T3 96 h prior to sacrifice restored EGF binding nearly to the control levels. Scatchard analysis of the binding data indicated that the decrease in EGF binding in hypothyroid membranes was due to a decrease in the number of the receptors. Affinity labeling/cross-linking of 125I-EGF to hepatic membranes with disuccinimidyl suberate followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography revealed a prominent band of Mr = 170,000, which was decreased in hypothyroid samples to the same extent as EGF binding. EGF-stimulated receptor kinase activity in detergent extracts of hepatic membranes also revealed a major phosphorylated protein species of Mr = 170,000, which was also decreased in samples from hypothyroid animals to approximately the same degree as EGF binding. Binding, affinity labeling/cross-linking, and phosphorylation measurements thus indicate that the levels of hepatic EGF receptor are regulated by thyroid status. These results raise the possibility that some in vivo affects of thyroid hormones may be mediated by alterations in EGF receptor levels.

摘要

研究了碘化表皮生长因子(125I-EGF)与正常甲状腺和甲状腺功能减退大鼠肝脏膜制剂的结合情况,以确定甲状腺激素是否调节EGF受体。与正常甲状腺对照组相比,甲状腺功能减退肝脏膜制剂中的结合仅为30%-40%。在处死前96小时用单剂量L-T3治疗甲状腺功能减退动物,可使EGF结合几乎恢复到对照水平。对结合数据的Scatchard分析表明,甲状腺功能减退膜中EGF结合的减少是由于受体数量的减少。用辛二酸二琥珀酰亚胺酯将125I-EGF与肝细胞膜进行亲和标记/交联,随后进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和放射自显影,显示出一条突出的Mr = 170,000条带,在甲状腺功能减退样品中该条带与EGF结合减少的程度相同。肝细胞膜去污剂提取物中EGF刺激的受体激酶活性也显示出一种主要的Mr = 170,000磷酸化蛋白,在甲状腺功能减退动物的样品中该蛋白也减少到与EGF结合大致相同的程度。因此,结合、亲和标记/交联和磷酸化测量表明,肝脏EGF受体水平受甲状腺状态调节。这些结果增加了甲状腺激素的一些体内作用可能由EGF受体水平改变介导的可能性。